Results 121 to 130 of about 6,025 (175)
Trends in antidote use in France from 2015 to 2021: a nationwide poison centers study. [PDF]
Pouget AM +7 more
europepmc +1 more source
Stereoselective Synthesis of Aminals Through Enzyme-Catalyzed Intermolecular C(sp<sup>3</sup>)-H Amidation of Azacycles. [PDF]
Chattopadhyay A, Roy S, Fasan R.
europepmc +1 more source
Medial prefrontal cortex acetylcholine signaling mediates the ability to learn an active avoidance response following learned helplessness training. [PDF]
Abdulla ZI +6 more
europepmc +1 more source
Imaging [18F]FDG PET/CT pilot study of nicotinic acetylcholinergic receptor α2 knock-out mice and α2 hypersensitive mice compared to control mice: Male-female differences and nicotine effects. [PDF]
Liang C +8 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Archives of General Psychiatry, 1978
Seven men and one woman with primary affective disorder, mania, were given a slow intravenous infusion of physostigmine salicylate. In six patients, mood and thought content changed from mania toward depression as evaluated by either a visual analog mood scale or the Pettersen scale.
K L, Davis +3 more
openaire +2 more sources
Seven men and one woman with primary affective disorder, mania, were given a slow intravenous infusion of physostigmine salicylate. In six patients, mood and thought content changed from mania toward depression as evaluated by either a visual analog mood scale or the Pettersen scale.
K L, Davis +3 more
openaire +2 more sources
2007
Physostigmine is a cholinesterase inhibitor belonging to the carbamate class. It is also referred to as an indirectly acting cholinomimetic because, by inhibiting acetylcholinesterase, it potentiates responses to endogenous acetylcholine, which is released from cholinergic nerve endings in the central nervous system and periphery.
openaire +2 more sources
Physostigmine is a cholinesterase inhibitor belonging to the carbamate class. It is also referred to as an indirectly acting cholinomimetic because, by inhibiting acetylcholinesterase, it potentiates responses to endogenous acetylcholine, which is released from cholinergic nerve endings in the central nervous system and periphery.
openaire +2 more sources
Bioavailability of Oral Physostigmine
New England Journal of Medicine, 1985Robin Whelpton
exaly +3 more sources

